Navigation Links
GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
Date:9/15/2009

with significant growth potential. Prime BioResearch currently has a proprietary portfolio of six worldwide patents in Obesity and Diabetes-II with of $2.9 billion, if successfully brought through development, clinical trials, and to market (Source: PriceWaterhouseCoopers). The Company's mission is to make safe and effective drugs available to the public, quickly and at affordable levels.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec. Visit GENova online at: www.genovabio.com.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business c
'/>"/>

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
2. GENova gains access to Big Pharma
3. GENova appoints Dr. Wang Chong to Scientific Advisory Board
4. GENova appoints Dr. Philip Gould to Scientific Advisory Board
5. GENova issues clarifying press release
6. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
7. GENova files patent for new breast cancer treatment
8. GENova appoints Director of Asian business development
9. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
10. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
11. Genova files patent for new prostate cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... Today marks a ... which invests in women-led, growth companies and is led by a group of experienced ... responded positively, and voted with their dollars to be a part of the fund. ...
(Date:7/29/2015)... ... ... are privileged to announce that U.S. News & World Report has ranked the ... the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye Institute ... honor to be included in the top 10 ophthalmology hospitals by U.S. News & World ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline ... fall of 2015 on RFD-TV. , Fastline is dedicated to quality agricultural advertising, ... which contains the largest and freshest searchable agriculture equipment database in the world. ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by ... in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine ... with demonstrated financial need. , “We are thrilled for this opportunity to offer ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for ... is a tremendous model of care. One that is very hands on and resident ... director of Monarch Landing. “She’s bringing great passion and energy, as well as a ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3
... Calif., March 11 HOYA ConBio(TM), a global,leader ... dentists who,purchase DioDent(TM) Micro 980 soft tissue lasers ... Advanced Laser,Training, a company dedicated to dental laser ... ConBio,s corporate commitment to comprehensive,laser dentistry education., ...
... EUSA,s Transatlantic ... Commercialization Platform ... Raises Over US$50 Million to Fund Acquisition and Other Investments, ... Inc (,EUSA,), a transatlantic specialty pharmaceutical company,focused on oncology, pain ...
... $0.51 Price Target, DALLAS, March 11 ... staffing company, today announced that,Wasserman Morris & Company, ... Company with a ,Speculative Buy, rating and a,price ... available at, http://www.crdentia.com/corporate/about/investor/ and through, http://www.wassermanmorris.com ., ...
... Cardiac Science,Corporation (Nasdaq: CSCX ), a ... and informatics products, announced that,Mexico,s Instituto de ... Estado (ISSSTE) ordered 282 electrocardiograph systems (ECGs) ... Science history. Instrumentation,Technologies de Mexico, Cardiac Science,s ...
... Now Available in Europe, Asia and Latin America, ... today that it has received CE Mark (Conformite Europeene),approval ... Everolimus Eluting,Coronary Stent System, offering physicians a smaller stent ... deliverability of,XIENCE V. The addition of the 2.25 mm ...
... a longtime resident of Southern,Nevada, I share our community,s ... this situation. I understand that many have questions about ... Endoscopy Center of,Southern Nevada. While I wish I were ... do so at this time on the advice of ...
Cached Medicine News:Health News:HOYA ConBio Partners With Advanced Laser Training to Offer Complementary Laser Certification Course in Dentistry 2Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 2Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 3Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 4Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 5Health News:Wasserman Morris Initiates Research Coverage on Crdentia 2Health News:Cardiac Science Delivers Largest Order of Electrocardiograph Systems in Company History 2Health News:Cardiac Science Delivers Largest Order of Electrocardiograph Systems in Company History 3Health News:Cardiac Science Delivers Largest Order of Electrocardiograph Systems in Company History 4Health News:Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent 2Health News:Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent 3
(Date:7/29/2015)... 29, 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ... revenue interest assignment agreement (the "Agreement") in which it ... ARIA ) with up to $200 million in revenue ... revenues of Iclusig ® (ponatinib).  Funding of the ... of $50 million each, with the initial amount having ...
(Date:7/29/2015)... , July 29, 2015 Touro College has announced ... CanniCare,s application for one of five media marijuana licenses to ... Dept. of Health (DOH).  If CanniCare ... medicinal cannabis.  "Our college is supportive of ... president of the Touro College System. "There is still a ...
(Date:7/29/2015)... July 29, 2015  Henry Schein, Inc. (NASDAQ: ... health care products and services to office-based dental, ... second quarter financial results. Net sales ... $2.6 billion, an increase of 0.5% compared with ... 7.5% growth in local currencies and a 7.0% ...
Breaking Medicine Technology:PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5Touro College Announces Support for CanniCare's Medical Cannabis License Application 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25
This adjustable lid speculum is angled 45 degrees and has 17 mm wire blades. It was designed to aspirate excess fluid around the eye during cataract and refractive procedures....
Angled 45 degrees. Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Open blade design with aspiration capabilities for removing fluids from the operative site....
Solid 15 mm blades with 8 mm narrowed portion. Screw-controlled locking mechanism with stabilizing disk. Dull finish....
Medicine Products: